Knocking-down of Nogo-A gene expression in PC12 cell line by plasmid-based RNAi

Abstract

To study the inhibitory effect of Nogo-A shRNA on cell line PC12, the Nogo-A shRNA (short hairpin RNA, or shRNA) was designed and synthesized. The annealed shRNA template was inserted into plasmid pGenesil-1 containing enhanced green fluorescent protein (EGFP) gene by gene cloning technique to generate eukaryotic expression vector. The recombinant plasmid was transfected into PC12 cells by lipofecamine2000 and the mRNA and protein expression level of Nogo-A gene was detected by RT-PCR and Western blotting 48 h after the transfection. Gene sequencing showed that that the Nogo-A shRNA eukaryotic expression vector was successfully constructed. No significant change was found in the Nogo-A mRNA and protein expression level in empty vector-transfected group as compared with controls (P>0.05), while the expression level in shRNA-transfected group decreased significantly (P<0.05). It is concluded that the pGenesil-1/Nogo-AshRNA recombinant plasmid can effectively suppress the expression of Nogo-A gene in PC12 cells.

Keywords

Nogo-A / RNA interference / plasmid / PC12 cell line

References

[1] ChenM. S., HuberA. B., van der HaarM. E.. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature, 2000, 403(6768): 434-439

[2] BlochlingerS., WeinmannO., SchwabM. E.. Neuronal plasticity and formation of new synaptic contacts follow pyramidal lesions and neutralization of Nogo-A: a light and electron microscopic study in the pontine nuclei of adult rats. J Comp Neurol, 2001, 433(3): 426-436

[3] HuberA. B., WeinmannO., BrosamleC., et al.. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci, 2002, 22(9): 3553-3567

[4] WangX., ChunS. J., TreloarH.. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci, 2002, 22(13): 5505-5515

[5] HasegawaT., OhnoK., SanoM., et al.. The differential expression patterns of messenger RNAs encoding Nogo-A and Nogo-receptor in the rat central nervous system. Brain Res Mol Brain Res, 2005, 133(1): 119-130

[6] GrandPreT., NakamuraF., VartanianT., et al.. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature, 2000, 403(6768): 439-444

[7] SendenN. H., TimmerE. D., de BruineA., et al.. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers. J Pathol, 1997, 182(1): 13-21

[8] SteinerP., KulangaraK., SarriaJ. C., et al.. Reticulon 1-C/neuroendocrine-specific protein-C interacts with SNARE proteins. J Neurochem, 2004, 89(3): 569-580

[9] HeW., LuY., QahwashI., et al.. Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation. Nat Med, 2004, 10(9): 959-965

[10] WakanaY., KoyamaS., NakajimaK., et al.. Reticulon 3 is involved in membrane trafficking between the endoplasmic reticulum and Golgi. Biochem Biophys Res Commun, 2005, 334(4): 1198-1205

[11] ChenM. S., HuberA. B., van der HaarM. E., et al.. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature, 2000, 403(6768): 434-439

[12] LiuH., NgC. E., TangB. L.. Nogo-A expression in mouse central nervous system neurons. Neurosci Lett, 2002, 328(3): 257-260